Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Gogolak

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Drug Safety|June 20, 2002
Good pharmacovigilance practices: technology enabledRobert C Nelson, Bruce Palsulich, Victor Gogolak
Archives of Internal Medicine|March 30, 2011
The FDA drug safety surveillance program: adverse event reporting trendsSheila Weiss-Smith, Gaurav Deshpande, Stephanie Chung, et al.
Pharmacoepidemiology and Drug Safety|August 31, 2006
Accelerating statistical research in drug safetyWarren Bilker, Victor Gogolak, David Goldsmith, et al.
Medgenmed : Medscape General Medicine|August 24, 2006
Rosuvastatin: an independent analysis of risks and benefitsDouglas P Zipes, Nathan J Zvaifler, Richard J Glassock, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Drug Safety|June 20, 2002
Good pharmacovigilance practices: technology enabledRobert C Nelson, Bruce Palsulich, Victor Gogolak
Archives of Internal Medicine|March 30, 2011
The FDA drug safety surveillance program: adverse event reporting trendsSheila Weiss-Smith, Gaurav Deshpande, Stephanie Chung, et al.
Pharmacoepidemiology and Drug Safety|August 31, 2006
Accelerating statistical research in drug safetyWarren Bilker, Victor Gogolak, David Goldsmith, et al.
Medgenmed : Medscape General Medicine|August 24, 2006
Rosuvastatin: an independent analysis of risks and benefitsDouglas P Zipes, Nathan J Zvaifler, Richard J Glassock, et al.
Pageof 1